4.6 Editorial Material

Primary Hyperoxaluria: A Need for New Perspectives in an Era of New Therapies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Urology & Nephrology

Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial

Mini Michael et al.

Summary: The study evaluates the efficacy, safety, pharmacokinetics, and pharmacodynamics of lumasiran in patients with primary hyperoxaluria type 1 (PH1) and advanced kidney disease. Lumasiran significantly reduces POx and improves other pharmacodynamic parameters. The study supports the efficacy and safety of lumasiran in patients with PH1 and advanced kidney disease.

AMERICAN JOURNAL OF KIDNEY DISEASES (2023)

Review Urology & Nephrology

Treatment of primary hyperoxaluria type 1

Asheeta Gupta et al.

Summary: Supportive treatment for PH1 includes high fluid intake and crystallization inhibitors. Pyridoxine and RNA interference agents can reduce urinary oxalate. Kidney dysfunction often leads to end-stage kidney disease and systemic oxalate deposition. Hemodialysis and liver transplantation are important treatments.

CLINICAL KIDNEY JOURNAL (2022)

Article Medicine, General & Internal

Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1

Sander F. Garrelfs et al.

Summary: Primary hyperoxaluria type 1 is a rare genetic disease caused by hepatic overproduction of oxalate, leading to kidney stones, nephrocalcinosis, kidney failure, and systemic oxalosis. This trial tested the efficacy of lumasiran, an RNAi therapeutic agent, in reducing hepatic oxalate production. The results showed that lumasiran significantly reduced urinary oxalate excretion, alleviating the cause of kidney failure in PH1 patients.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Surgery

Primary hyperoxaluria diagnosed after kidney transplant: A review of the literature and case report of aggressive renal replacement therapy and lumasiran to prevent allograft loss

Hillarey K. Stone et al.

Summary: Primary hyperoxaluria type 1 is a rare genetic disorder that can be easily missed and lead to poor outcomes post-transplant, highlighting the importance of early detection and intervention to prevent adverse consequences in patients with chronic kidney disease.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

Review Urology & Nephrology

Recent advances in the identification and management of inherited hyperoxalurias

David J. Sas et al.

UROLITHIASIS (2019)

Review Medicine, General & Internal

Primary Hyperoxaluria

Pierre Cochat et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Urology & Nephrology

Characteristics and Outcomes of Children with Primary Oxalosis Requiring Renal Replacement Therapy

Jerome Harambat et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)

Article Transplantation

Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment

Pierre Cochat et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)

Article Urology & Nephrology

The primary hyperoxalurias: An algorithm for diagnosis

DS Milliner

AMERICAN JOURNAL OF NEPHROLOGY (2005)

Article Urology & Nephrology

Clinical implications of mutation analysis in primary hyperoxaluria type 1

CS van Woerden et al.

KIDNEY INTERNATIONAL (2004)